NPI: 1073581310 · TEMPLE TERRACE, FL 33617 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,356 | $1.66M |
| 2019 | 26,711 | $3.60M |
| 2020 | 29,229 | $4.13M |
| 2021 | 20,361 | $1.77M |
| 2022 | 10,265 | $1.52M |
| 2023 | 778 | $62K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,856 | 2,216 | $4.09M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,810 | 1,763 | $3.40M |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,957 | 1,542 | $2.38M |
| A4657 | Syringe, with or without needle, each | 5,758 | 1,858 | $1.08M |
| J1756 | Injection, iron sucrose, 1 mg | 7,173 | 1,522 | $705K |
| 85041 | 1,724 | 1,125 | $207K | |
| 85048 | 1,695 | 1,111 | $204K | |
| 83970 | 1,471 | 990 | $175K | |
| 82728 | 1,104 | 743 | $127K | |
| 83550 | 1,082 | 725 | $124K | |
| 83540 | 1,096 | 737 | $124K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 386 | 261 | $44K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 243 | 110 | $28K |
| 82108 | 128 | 94 | $18K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 48 | 12 | $11K |
| 90674 | 86 | 57 | $10K | |
| G0008 | Administration of influenza virus vaccine | 83 | 57 | $9K |